SCHEMBL7475340

SCHEMBL7475340

COC(=O)c1ccc(N2CCC[C@@H](Nc3ncccn3)C2)c(F)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
KDM4E B2RXH2 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ALDH1A1 P00352 3/20 0.41
BPTF Q12830 1/20 0.41
CCNT1 O60563 1/20 0.41
CCNK O75909 1/20 0.41
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
CDK7 P50613 1/20 0.41
CDK9 P50750 1/20 0.41
CCNH P51946 1/20 0.41
CDK13 Q14004 1/20 0.41
CDK12 Q9NYV4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7468744 1.00 CYP1A2 (0.43) CYP1A2CYP3A4CYP2C9CYP2C19KDM4E
SCHEMBL7474491 0.89 KDM4E (0.43) KDM4ENPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL7469825 0.89 MEN1 (0.41) KDM4ENPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL7462642 0.89 MEN1 (0.41) KDM4ENPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL382924 0.88 ALDH1A1 (0.48) CYP1A2CYP3A4CYP2C9CYP2C19KDM4E
SCHEMBL7473696 0.83 OPRK1 (0.42) KDM4EALDH1A1ROCK2ROCK1CDC42BPB
SCHEMBL7468715 0.80 RPS6KB1 (0.37) KDM4ENPC1RAB9ANPSR1ALDH1A1
SCHEMBL6507428 0.79 KDM4E (0.46) CYP1A2CYP3A4KDM4ENPC1RAB9A
SCHEMBL7468740 0.79 CYP1A2 (0.43) CYP1A2CYP3A4CYP2C9CYP2C19KDM4E
SCHEMBL7470496 0.79 DPP4 (0.52) CYP1A2CYP3A4CYP2C9CYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1227083-A1 3-AMINOPIPERIDINE DERIVATIVES AS INTEGRIN $g(a)v$g(b)3 ANTAGONISTS MEIJI SEIKA KAISHA LTD. (JP) 2002-07-31 EP disclosed